Officially Open to the Public: IMI's Support for the Grand Opening of RAHO Club Lakesla Branch 14:38, 09 October 2024 by admin
Ceremony for the First Phase 3 Clinical Trial of Intravenous Hydrogen Nano Bubble Injection in Parkinsonism Patients at RSUB 14:36, 09 October 2024 by admin
The Synergy of IMI, RAHO Club, and Lakesla: Breakthrough in Hydrogen Nanobubble Therapy for Patients with Degenerative Diseases 14:33, 09 October 2024 by admin
Collaborating with Faculty of Computer Science UB, IMI Utilizes AI to Study Nano Bubble Technology 15:14, 29 July 2024 by admin
Comprehensive Clinical Evaluation and Therapeutic Progression of a 70-Year-Old Female Following Ischemic Infarction: A Case Study in Integrated Pharmacotherapy and Intravenous Oxyhydrogen-Nitric Oxide Nanobubble Intervention 13:39, 30 September 2026 by admin
Reduction of Coronary Artery Stenosis Following Oxyhydrogen and Gasotransmitter Nanobubble Infusions: A Case Report 15:51, 16 September 2026 by admin
Oxyhydrogen nanobubbles attenuate angiogenesis, inflammation, and immunosuppression in Wistar rats hepatocellular carcinoma model 15:44, 16 September 2026 by admin
Hydrogen Nanobubble Therapy and Chronic Coronary Artery Disease: Lessons from a Case Report 13:40, 03 September 2026 by admin
